Answer
Breastfeeding should be avoided throughout cemiplimab treatment and for at least 4 months after the last dose.
Sources for this answer
- LIBTAYO 350 mg concentrate for solution for infusion.Regeneron UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 25Document updated
Sources checked